Cameco Corporation

New York Stock Exchange
Back to all articles
Bullish +65

Amova Asset Management Americas Inc. Purchases 143,113 Shares of Cameco ...

📈 Amova Asset Management Americas Inc. increased its Cameco holdings by 37.7% in Q1, adding 143,113 shares to a total position of 522,864 shares.

💰 The institutional stake held by Amova is valued at $56,788,000 based on the most recent SEC filing data.

📊 Other major investors including Clearstead Advisors and Legacy Bridge also grew their stakes in Cameco during the fourth quarter.

🎯 Truist Financial initiated coverage with a 'buy' rating and set a $129.00 price target for the stock.

📉 TD Securities downgraded Cameco from a 'strong-buy' to a 'hold' rating in a March report.

💵 Bank of America lowered its price objective from $143.00 to $140.00 while maintaining a 'buy' rating.

📉 The stock currently trades at $84.84, which is below both the 50-day ($103.12) and 200-day ($110.75) moving averages.

🏦 Cameco maintains a robust balance sheet with a debt-to-equity ratio of 0.14 and a current ratio of 3.08.

🌍 The company operates primarily in Canada and the United States, focusing on uranium mining and processing.

📈 MarketBeat data indicates an average analyst price target of $146.18 for Cameco Corporation.

Bullish Signals
  • Amova Asset Management Americas Inc. significantly increased its position by 37.7% in the first quarter, signaling strong institutional confidence.
  • Multiple other institutional investors including Clearstead Advisors and Legacy Bridge also added to their stakes during the fourth quarter.
  • The company possesses a very low debt-to-equity ratio of 0.14, indicating minimal financial leverage risk.
  • Liquidity is strong with a current ratio of 3.08 and a quick ratio of 2.09.
  • Truist Financial initiated coverage with a 'buy' rating and a $129 target price, which is above the current trading level.
  • Scotiabank reaffirmed an 'outperform' rating with a high $175.00 price objective.
  • Bank of America maintains a 'buy' rating despite lowering its specific price target.
  • The average analyst price target of $146.18 suggests significant upside potential from the current trading price of roughly $85.
Risk Factors
  • TD Securities downgraded the stock from a 'strong-buy' to a 'hold' rating in June.
  • Bank of America recently decreased its price objective from $143.00 to $140.00.
  • The current stock price of $84.84 is trading below both the 50-day and 200-day moving averages, indicating recent underperformance.
Full Analysis
Amova Asset Management Americas Inc. significantly increased its stake in Cameco Corporation (CCJ) by purchasing an additional 143,113 shares in the first quarter, representing a 37.7% lift in its position. Following this purchase, Amova holds 522,864 shares valued at approximately $56.8 million according to recent SEC filings. Several other institutional investors also adjusted their positions during the fourth quarter and first quarter, with Clearstead Advisors, Legacy Bridge, HB Wealth Management, Groupama Asset Management, and S.A. Mason all increasing their holdings in the uranium producer. Analyst sentiment regarding CCJ remains mixed but generally leans positive based on average price targets exceeding current trading levels. Truist Financial initiated coverage with a 'buy' rating and a $129 target price, while Scotiabank maintains an 'outperform' rating with a $175 objective. Conversely, TD Securities downgraded the stock to a 'hold,' and Bank of America recently lowered its price target from $143 to $140, though it retained a 'buy' rating. The consensus average price target stands at $146.18. Financially, Cameco operates with a strong balance sheet characterized by a low debt-to-equity ratio of 0.14 and healthy liquidity metrics including a current ratio of 3.08. The stock currently trades around $84.84, significantly below its 50-day moving average of $103.12 and 200-day average of $110.75, suggesting potential upside relative to recent technical averages. With a market capitalization of roughly $36.95 billion, the company is viewed as a leading producer of uranium concentrate for the global nuclear power industry.